70 results
424B3
VAPO
Vapotherm Inc
5 May 23
Prospectus supplement
4:06pm
independently, the Company believes leveraging the two together can create a unique healthcare ecosystem, focused on delivering high quality … ;
U.S. Food and Drug Administration or other United States or foreign regulatory actions affecting us or the healthcare industry generally, including
S-3/A
rjhgyavf4 zgd
3 May 23
Shelf registration (amended)
4:42pm
8-K
EX-10.1
1dsjvlh1oj12j
22 Nov 22
Vapotherm Announces Amendment to Debt Agreement
6:55am
8-K
EX-10.1
2xu9akkjnl0 1c
3 Oct 22
Vapotherm Announces Debt Amendment and NYSE Continued Listing Standard Notice
4:30pm
8-K
EX-10.3
tvpe ukk56aqzgxqqp
12 Apr 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
cas60 l25
12 Apr 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.2
ytb1p28l rrprngw3tt
12 Apr 22
Departure of Directors or Certain Officers
4:30pm